66th Annual Meeting
This annual meeting is designed for researchers, professors, government and public health officials, military personnel, travel clinic physicians, practicing physicians in tropical medicine, students and all health care providers working in the fields of tropical medicine, hygiene and global health.
DNDi took part in symposia, poster and oral presentation sessions at the meeting.
Symposium
Chagas disease: Regional differences in clinical research and patient care
Date: Wednesday, November 8, 2017
Organizer: Symposium Organizer: Sergio Sosa Estani, Drugs for Neglected Diseases initiative – Latin America, Rio de Janeiro, Brazil
| Real-world management of heart failure in Chagas disease: insights from the BENEFIT Trial Carlos Morillo, Alberta Health Services, Calgary, AB, Canada |
| Update current clinical trials for improving etiological treatment of Chagas disease Fabiana Barriera, Drugs for Neglected Diseases initiative, Rio de Janeiro, Brazil |
| Regional differences in congenital transmission of T. cruzi in Latin America Pierre Buekens, Tulane University, New Orleans, LA, United States |
| Decision-making algorithm for the evaluation of therapeutic response in the health care system Yanina Sguassero, Centro Rosarino de Estudios Perinatales, Rosario, Argentina |
Immigration and Chagas disease: Barriers to access to treatment and new challenges in the US, Europe and Latin America
Date: Wednesday, November 8, 2017
Organizer: Sheba K Meymandi, Center of Excellence for Chagas Disease at Olive View-UCLA Medical Center, Sylmar, CA, United States
| Migrants, infectious diseases and the political economic landscape in 2017 Peter J Hotez, Baylor University, Houston, TX, United States |
| Immigration and Chagas disease in Europe: new challenges Joaquim Gascon, Institut de Salut Global de Barcelona, Barcelona, Spain |
| Chagas disease in the Bolivian population of São Paulo, Brazil Maria A Shikanai-Yasuda, University of Sao Paulo School of Medicine, Sao Paulo, Brazil |
| Chagas disease in a time of immigrant backlash: challenges for expanding access to treatment in Los Angeles and beyond Colin J Forsyth, Drugs for Neglected Diseases initiative, New York, NY, United States |
Oral Presentations
Date: Monday, November 6, 2017
| Projected number of people with onchocerciasis-loiasis co-infection in Africa, 1995-2025 Vinkeles Melchers NVS, Tekle AH, Coffeng LE, Pion SDS, Zouré HGM, Pedrique B, Boussinesq M, Wanji S, Remme JHF, Stolk WA |
| Building a visceral leishmaniasis data-sharing platform to optimize treatment and inform future research Guerin PJ, Otieno M, Alvar J |
Date: Tuesday, November 7, 2017
| ABBV-4083: a clinical candidate for the treatment of onchocerciasis – efficacy in the L. sigmodontis rodent model Bloemker D, Hübner MP, Scandale I, von Geldern T, Marsh K, Taylor MJ, Kempf D, Hoerauf |
| Identification of potential clinical candidates with macrofilaricidal efficacy for the treatment of onchocerciasis Hübner MP, Hoerauf A, Blömker D, Townson S, Gokool S, Martin C, Vallarino-Lhermitte N, Chojnowski A, Kreiss T, Prorok M, Siekierka J, Khetani V, Camardo J, Canan S, Scandale I, Hawryluk N |
Poster Presentations
| Designing antifilarial drug trials using clinical trial simulators Walker M, Milton P, Monnot F, Pedrique B, Basáñez MG |
| Surrogate markers of cure for Chagas disease in children treated with Benznidazole Ruiz-Lancheros E, Chatelain E, Bournissen F, Moroni S, Moscatelli G, Altcheh J, Ndao M |
| Comparison of the in vitro susceptibility to emodepside of microfilariae, third stage larvae and adult worms of related filarial nematodes Kulke D, Townson S, Bloemker D, Frohberger S, Specht S, Scandale I, Glenschek-Sieberth M, Harder A, Hoerauf A, Hübner MP |
More information:
